Skip to main content

Pain and Pain-Related Neuropsychiatric Disorders: From Mechanistic Insights to Innovative Therapeutic Strategies

114kviews
Editorial25 March 2025
Editorial: Pain and pain-related neuropsychiatric disorders: from mechanistic insights to innovative therapeutic strategies

A fundamental step toward improving chronic pain treatment lies in deciphering its underlying neurobiological mechanisms with the use of well-characterised animal models. In this regard, the preclinical study by Di Marino et al. extends behavioural characterisation of the paclitaxel model of chemotherapy-induced neuropathic pain in rats of both sexes, and sheds light on the status of the endocannabinoid system in this model. Their work lays a solid foundation for potential targeting of endocannabinoid signalling as a novel therapeutic strategy. The endocannabinoid system is explored also in the work by Yuan et al. They explore novel pathways, including the role of VD-hemopressin (α) and RVD-hemopressin (α) in electroacupuncture-mediated pain relief, highlighting a role for the cannabinoid type 1 (CB1) receptor. Qu et al. further elaborate on neuropathic pain mechanisms, demonstrating the efficacy of the plant Dahuang Fuzi, whose decoction has been used for millennia in traditional Chinese medicine, in inhibiting TNF-α and PI3K-AKT signalling in the chronic constriction injury model (CCI) of neuropathic pain. Novel insight on thermal nociception is offered by Engel et al. Their work investigates the interplay between sodium-activated potassium channel Slick (Kcnt2) and the transient receptor potential melastatin (TRPM3), which is highly co-expressed in specialised heatsensitive neurons, highlighting possible new pharmacological targets.Clinical studies included in this collection represent a significant contribution to developing patientcentered interventions.Baeumler et al. contribute to the ongoing debate on predicting acupuncture analgesic response in relation to high temporal summation (TS), reporting that acupuncture effectively reduces pain in patients with chronic non-specific low back pain (LBP) regardless of TS levels, supporting its use as a viable treatment for a broader population. The clinical trial by Scuteri et al. presents compelling evidence on the efficacy of a nanoparticle formulation of bergamot essential oil (NanoBEO) in managing both pain and agitation in patients with severe dementia, highlighting a natural-derived alternative to conventional analgesics in these complex patients already undergoing polypharmacotherapy. Takahashi et al. further explore the neuropsychiatric component in ADHD-comorbid nociplastic pain, highlighting the functional hyperactivity of the praecuneus, a key brain region involved in self-referential thinking, attention, and pain processing. A focus on the affective component, including the pain catastrophizing, of menstrual pain is given by Hsu et al.. They investigate how catechol-O-methyltransferase (COMT) Val158Met polymorphisms influence the top-down pain modulation within the reward system, significantly contributing to individual differences in pain regulation. Papa et al. provide crucial long-term data on buprenorphine transdermal patches, demonstrating its sustained analgesic effects with reduced side effects and reduced risk of addiction compared to other opioids, reinforcing its role as a viable option for chronic pain management. Finally, the metabolomic profile of the novel anti-NGF antibody DS002 is reported by Jin et al.. This phase I study shows how cartilage and bone metabolism are not significantly affected by treatment with the antibody, suggesting that DS002 may offer a safer alternative to existing anti-NGF analgesics with fewer joint-related adverse effects.Systematic reviews also play a pivotal role in consolidating knowledge and guiding future research.The meta-analysis by Peng et al. on levetiracetam for paediatric migraine prophylaxis offers valuable insights into its efficacy and underscores the need for further exploration on its safety profile. Starting from a case report, the scoping review by Peraire et al. on ziconotide-related psychosis raises awareness of the neuropsychiatric implications of this treatment. A mechanism related to the blockade of N-type voltage-gated calcium channels in glutamatergic and GABAergic neurons is hypothesised, highlighting the critical need to balance pain relief and patient safety.As the field evolves, reviews provide a comprehensive synthesis of emerging trends and future perspectives. The discussion by Yang et al. on mirogabalin as a novel calcium channel α2δ ligand underscores its promising role in the treatment of neuropathic pain and related comorbidities. Finally, Kasahara et al. explore the potential of ADHD medications for chronic pain management, opening new interdisciplinary avenues.Looking ahead, advancing personalized medicine, exploring sex-specific differences, and targeting novel pharmacological pathways will refine pain treatment. Integrating mechanistic insights with clinical applications is essential for addressing pain and its neuropsychiatric complexities. This Research Topic highlights the crucial link between basic and clinical research, pushing us closer to effective solutions for chronic pain and associated disorders.

1,539 views

Characterisation of the effects of the chemotherapeutic agent paclitaxel on neuropathic pain-related behaviour, anxiodepressive behaviour, cognition, and the endocannabinoid system in male and female rats
Paclitaxel (PTX) is a commonly used chemotherapeutic drug, however, one of its major adverse effects is chronic neuropathic pain, with the incidence being higher in women than in men. The neurobiological mechanisms behind this sex difference are still largely unclear, and the endocannabinoid system, which exhibits sexual dimorphism and plays a key role in pain regulation, is a promising area for further studies. The present study aimed to characterise pain-, cognition-, anxiety-, and depression-related behaviours in male and female rats following PTX administration, and associated alterations in the endocannabinoid system. After the induction of the model, pain-related behaviours were assessed using von Frey, Acetone Drop and Hargreaves’ tests, Novel Object Recognition and T-Maze Spontaneous Alternation tests were used for cognition-related behaviours, Elevated Plus Maze, Open Field, and Light Dark Box tests were used to assess anxiety-related behaviours, and Sucrose Preference, Sucrose Splash, and Forced Swim tests for depression-related behaviours. At each time point analysed, animals treated with PTX exhibited mechanical and cold hypersensitivity, with females displaying lower hind paw withdrawal thresholds to mechanical stimulation than males. No PTX-induced alterations in the other behavioural tests were detected. Post-mortem measurement of endocannabinoid and related N-acylethanolamine levels in spinal cord and discrete brain regions revealed a PTX-induced increase of 2-Arachidonoyl Glycerol (2-AG), N-Palmitoylethanolamine (PEA) and N-Oleoylethanolamine (OEA) levels in the amygdala of male and female animals, but not in the other areas. Collectively, these results suggest that PTX causes similar long-lasting hypersensitivity to mechanical and cold stimuli, but not heat, in rats of both sexes, effects accompanied by increases in amygdalar levels of endocannabinoids and N-acylethanolamines.

4,912 views

10 citations

ORIGINAL RESEARCH
11 December 2024
Analgesic effect of Dahuang Fuzi Decoction in neuropathic pain through inhibiting TNF-α and PI3K-AKT signaling
Jinglian Qu, 5 more and Peng Chen

3,732 views

4 citations

ORIGINAL RESEARCH
1 October 2024
Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain
Xiaocui Yuan, 8 more and Fuquan Huo

3,257 views

3 citations

CORRECTION
30 September 2024
Corrigendum: Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain
Alfonso Papa, 8 more and Sabatino Maione

1,582 views

2 citations

ORIGINAL RESEARCH
23 August 2024
Temporal summation does not predict the acupuncture response in patients with chronic non-specific low back pain
Petra Baeumler, 2 more and Dominik Irnich

3,187 views

1 citations

ORIGINAL RESEARCH
8 August 2024
Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain
Alfonso Papa, 8 more and Sabatino Maione

10,695 views

8 citations

ORIGINAL RESEARCH
6 August 2024
Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis
Jing Peng, 5 more and Zhisheng Liu

3,680 views

5 citations

CLINICAL TRIAL
1 August 2024
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial
Damiana Scuteri, 8 more and the Pilot BRAINAID Trial investigators

3,596 views

4 citations

ORIGINAL RESEARCH
12 August 2024
Effect of the novel anti-NGF monoclonal antibody DS002 on the metabolomics of pain mediators, cartilage and bone
Dandan Jin, 12 more and Juan Li

4,408 views

3 citations